Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Woman of the Future Award for Science

Awards and Appointments General

Rachel Tanner, Postdoctoral Research Scientist and Lecturer at the Jenner Institute (Nuffield Department of Medicine) has been awarded the 2019 'Woman of the Future Award for Science'

Image of Rachel Tanner who has been awarded the 2019 'Woman of the Future award for Science'

Rachel was selected for the award on the basis of her significant contribution to the field of tuberculosis vaccine development. Tuberculosis is currently the world’s most deadly infectious disease. The WHO estimates that 1.8 billion people, close to one quarter of the world's population, are infected with Mycobacterium tuberculosis, the bacteria that causes TB. Last year, 10 million fell ill from TB and 1.6 million people died.

She was also highly commended for her work to ensure greater parity among students at top universities and within STEM fields. 

Read more (The Jenner Institute)

Find out more about the Woman of the Future Award for Science

Similar stories

Student Prizes for Biomedical Sciences and Medicine 2021-2022

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2021-2022 academic year.

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Researchers discover novel form of adaptation in the auditory system

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have found that the auditory system adapts to the changing acoustics of reverberant environments by temporally shifting the inhibitory tuning of cortical neurons to remove reverberation.

20 minutes of daily exercise can keep teens' doctors away

Teenagers should exercise vigorously for at least 20 minutes per day to reap increased cardiorespiratory fitness (CRF), according to a cross-sectional study from the UK led by University of Oxford researchers.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.